SCHEMBL23866737

SCHEMBL23866737

CC(C)C1C=NN(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13233137 0.69 — —
SCHEMBL25122056 0.69 — —
SCHEMBL18435480 0.67 — —
SCHEMBL24737755 0.67 — —
SCHEMBL24737745 0.67 — —
SCHEMBL24574076 0.65 — —
SCHEMBL19820197 0.63 — —
SCHEMBL24574131 0.63 — —
SCHEMBL24574182 0.62 — —
SCHEMBL24438681 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105217-A1 3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER Daegu-Gyeongbuk Medical Innovation Foundation (KR) 2022-12-21 — — EP disclosed
US-20210298295-A1 COMPOUNDS AND COMPOSITIONS FOR NEMATODE TREATMENT IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2021-09-30 — — US disclosed
Send feedback